CAMBRIDGE, Mass., July 22, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the appointment of two new members to its Board of Directors: Martin Babler and Ian F. Smith. In addition, Infinity announced two leadership promotions within its executive leadership team: Michael S. Curtis, Ph.D. to vice president, pharmaceutical development and Jeanette Kohlbrenner to senior director, human resources. These appointments facilitate the advancement of Infinity’s mission to discover, develop, and deliver to patients important new medicines for the treatment of cancer, and they also reflect Infinity’s commitment to leadership development.
